These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6622343)

  • 1. Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BP.
    Hosker JP; Jewell DP
    Postgrad Med J; 1983 Aug; 59(694):514-5. PubMed ID: 6622343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired factor X deficiency in systemic amyloidosis.
    Lucas FV; Fishleder AJ; Becker RC; Cavalier DS; Tubbs RR
    Cleve Clin J Med; 1987; 54(5):399-406. PubMed ID: 3665021
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired, transient factor X (Stuart factor) deficiency in patient with mycoplasma pneumonial infection.
    Peuscher FW; van Aken WG; van Mourik JA; Swaak AJ; Sie LH; Statius van Eps LW
    Scand J Haematol; 1979 Oct; 23(4):257-64. PubMed ID: 538412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant hepatic failure associated with intravenous erythromycin lactobionate.
    Gholson CF; Warren GH
    Arch Intern Med; 1990 Jan; 150(1):215-6. PubMed ID: 2297290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency within the extrinsic prothrombin activator system in patients with acute spinal cord injury.
    Hachen HJ; Rossier AB; Bouvier CA; Ritschard J
    Paraplegia; 1974 Aug; 12(2):132-8. PubMed ID: 4427781
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of factor X deficiency in systemic amyloidosis.
    Furie B; Voo L; McAdam KP; Furie BC
    N Engl J Med; 1981 Apr; 304(14):827-30. PubMed ID: 7207512
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of acquired factor X deficiency with in vivo and in vitro evidence of inhibitor activity directed against factor X.
    Mulhare PE; Tracy PB; Golden EA; Branda RF; Bovill EG
    Am J Clin Pathol; 1991 Aug; 96(2):196-200. PubMed ID: 1862774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factor X deficiency in systemic amyloidosis. Presentation of a case].
    Ribera C; Delgado JM; Toledo T; Martín MA; Bornstein R; Fernández F
    Rev Clin Esp; 1986 Oct; 179(6):302-4. PubMed ID: 3797735
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic amyloidosis associated with factor X deficiency.
    Shibuya H; Azumi N; Abe F; Deno M; Sakurama S
    Acta Pathol Jpn; 1984 May; 34(3):639-47. PubMed ID: 6464754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor X deficiency in systemic amyloidosis.
    Fischer SP
    N Engl J Med; 1981 Jul; 305(3):174. PubMed ID: 7242595
    [No Abstract]   [Full Text] [Related]  

  • 11. Easy bruising but normal platelets in an old woman.
    Lazerson J
    Hosp Pract (Off Ed); 1984 Nov; 19(11):56A, 56B, 56F. PubMed ID: 6436272
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factor X deficiency and systemic amylosis].
    Pedinielli FJ; Mascret B; Blanc AP; Sudan N; Juhan-Vague I; Carcassonne Y
    Sem Hop; 1984 Mar; 60(11):792-4. PubMed ID: 6324362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxic reaction to erythromycin ethylsuccinate.
    Patel J; Schneider R
    South Med J; 1984 Oct; 77(10):1343-4. PubMed ID: 6333077
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired isolated factor X deficiency associated with systemic amyloidosis. Case report and review of literature.
    Girmann G; Wilker D; Stadie H; Scheurlen PG
    Klin Wochenschr; 1980 Sep; 58(17):859-62. PubMed ID: 7442086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive systemic sclerosis with the nephrotic syndrome and acquired factor X deficiency.
    Eiser AR; Zilversmit R; Neff MS; Grishman E; Slifkin RF
    Am J Nephrol; 1986; 6(1):61-5. PubMed ID: 3963060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment of Life-threatening Bleeding Caused by Acquired Factor X Deficiency Associated with Respiratory Infection.
    Ichikawa S; Saito K; Fukuhara N; Tanaka Y; Lee Y; Onodera K; Onishi Y; Yokoyama H; Fujiwara M; Harigae H
    Intern Med; 2020 May; 59(10):1303-1308. PubMed ID: 32023586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin ototoxicity in liver transplant patients.
    Moral A; Navasa M; Rimola A; García-Valdecasas JC; Grande L; Visa J; Rodés J
    Transpl Int; 1994; 7(1):62-4. PubMed ID: 8117405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin-induced hepatitis: simulator of malignancy.
    Rigauts HD; Selleslag DL; Van Eyken PL; Van Damme BJ; Fevery JM; Marchal GJ
    Radiology; 1988 Dec; 169(3):661-2. PubMed ID: 3055031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin-induced dynamic ileus?
    Heyman SN; Stalnikowicz R; Heyman A; Gilon D; Mogle P
    J Clin Gastroenterol; 1988 Oct; 10(5):551-4. PubMed ID: 3183328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of typhoid fever complicated by a severe bleeding syndrome due to deficiency of the prothrombin group of coagulation factors.
    Greig HB; Naidoo PD
    J Trop Med Hyg; 1981 Dec; 84(6):253-7. PubMed ID: 6976439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.